GH fundamentals
Key facts
Market capitalization5.41 BUSD
Basic EPS (TTM)−3.56USD
Founded2011
Employees (FY)2.02 K
CEO—
Websiteguardanthealth.com
About
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−123%
−106%
−89%
−72%
−55%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−220.00 M
−110.00 M
0.00
110.00 M
220.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
GH does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company